Christopher Pazdan net worth and biography

Christopher Pazdan Biography and Net Worth

Chief Operating Officer of KORU Medical Systems

Chris joins the KORU team from Hillrom where he worked as the Vice President of Quality Assurance. In that role he was responsible for all quality functions for Hillrom’s largest manufacturing division. Prior to that role, Chris was the Vice President of QA/RA where he was responsible for enterprise-wide Design Assurance, Supplier Quality Assurance, Project Management Office, and Software. Chris’ proudest professional accomplishments include working with, leading, and helping build great teams. In addition to these efforts, he enjoys making a difference in the healthcare space and improving outcomes for patients and customers.

Chris received his bachelor’s degree in general engineering from the University of Illinois at Urbana-Champaign. He is a ASQ Certified Six Sigma Black Belt, ASQ Certified Quality Engineer and an ASQ Certified Quality Auditor.

What is Christopher Pazdan's net worth?: The estimated net worth of Christopher Pazdan is at least $1.23 million as of May 14th, 2026. Mr. Pazdan owns 305,131 shares of KORU Medical Systems stock worth more than $1,229,678 as of July 22nd. This net worth evaluation does not reflect any other assets that Mr. Pazdan may own. Learn More about Christopher Pazdan's net worth.
How do I contact Christopher Pazdan?: The corporate mailing address for Mr. Pazdan and other KORU Medical Systems executives is 24 CARPENTER RD, CHESTER NY, 10918. KORU Medical Systems can also be reached via phone at (845) 469-2042 and via email at [email protected]. Learn More on Christopher Pazdan's contact information.
Has Christopher Pazdan been buying or selling shares of KORU Medical Systems?: Christopher Pazdan has not been actively trading shares of KORU Medical Systems in the last ninety days. Most recently, on Thursday, May 14th, Christopher Pazdan bought 5,000 shares of KORU Medical Systems stock. The stock was acquired at an average cost of $3.88 per share, with a total value of $19,400.00. Following the completion of the transaction, the chief operating officer now directly owns 305,131 shares of the company's stock, valued at $1,183,908.28. Learn More on Christopher Pazdan's trading history.
Who are KORU Medical Systems' active insiders?: KORU Medical Systems' insider roster includes Thomas Adams (Chief Financial Officer), James Beck (Director), Adam Kalbermatten (President and Chief Executive Officer), Joseph Manko, Jr. (Director), Christopher Pazdan (Chief Operating Officer), and Eric Schiller (Chief Technology Officer). Learn More on KORU Medical Systems' active insiders.
Are insiders buying or selling shares of KORU Medical Systems?: In the last twelve months, KORU Medical Systems insiders bought shares 4 times. They purchased a total of 28,000 shares worth more than $109,430.00. The most recent insider tranaction occured on June, 11th when insider Adam R Kalbermatten bought 12,500 shares worth more than $49,250.00. Insiders at KORU Medical Systems own 18.5% of the company. Learn More about insider trades at KORU Medical Systems.
Information on this page was last updated on 6/11/2026.

Christopher Pazdan Insider Trading History at KORU Medical Systems

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
5/14/2026	Buy	5,000	$3.88	$19,400.00	305,131

Christopher Pazdan Buying and Selling Activity at KORU Medical Systems

KORU Medical Systems Company Overview

KORU Medical Systems, Inc. develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products. The company was incorporated in 1980 and is based in Mahwah, New Jersey.

Today's Range

Now: $3.86

$3.83

$4.03

50 Day Range

MA: $4.12

$3.83

$4.60

2 Week Range

Now: $3.86

$3.20

$6.61

Volume

148,768 shs

Average Volume

160,699 shs

Market Capitalization

$177.07 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.41